# Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed

> **NCT04386980** · PHASE3 · WITHDRAWN · sponsor: **Sorrento Therapeutics, Inc.**

## Conditions studied

- Osteoarthritis, Knee
- Osteo Arthritis Knee
- Knee Pain Chronic

## Interventions

- **DRUG:** Resiniferatoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04386980
- **Lead sponsor:** Sorrento Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** To be replaced by a different protocol
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386980, "Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04386980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*